CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy
Wei‐Ting Wang(Institute of Molecular Biology, Academia Sinica), Wei Xu(Jiangsu Province Hospital), Yifan Wu(Jiangsu Province Hospital), Kai‐Xin Du(Jiangsu Province Hospital), Zi‐Wen Duan(Jiangsu Province Hospital), Yue Li(Southwest Petroleum University), Jianyong Li(Jiangsu Province Hospital), Hua Yin(Jiangsu Province Hospital), Jia‐Zhu Wu(Augusta University Health), Jin‐Hua Liang(Broad Institute), Li Wang(University of Science and Technology of China), Jing-Ran Guo(Jiangsu Province Hospital), Tong‐Yao Xing(Jiangsu Province Hospital), Hao-Rui Shen(Nanjing Medical University)
Cited by 18
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U
|The Journal of Experimental Medicine|2010|240
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|238